Page 95 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
N, López-Muñoz N, Sánchez-Pina JM, Colmenares R, Sánchez-Beato M, Piris MA, Plaza Menacho I, Kemal Samur M, Munshi NC, Ayala R, Kortuem KM, Barrio S, Martínez-López J . Grupo de trabajo coautor: GEM .
• Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma In- cluded in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
De La Rubia J, Alonso R, Clavero Sánchez ME, Askari E, García de Coca A, Maldonado A, Fernández De La Mata M, Escalante F, García-Feria A, Ríos R, Conesa V, Bermúdez MA, Merchán B, Velasco A, Blanchard MJ, Sampol A, Gainza González E, Hernández PM, González-Calle V, Alegre A .
Grupo de trabajo coautor: GEM .
• Belantamab Mafodotin in Combination with VRD for the Treatment of Newly Diag- nosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELA-VRD Trial.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
González-Calle V, Rodríguez Otero P, Rey-Bua B, De La Rubia J, De Arriba F, Cabañas V, González García E, Ocio EM, Encinas C, Suárez Cabrera A, Bargay J, Martínez López J, González MS, Hernández-Rivas JA, Rosiñol L, Hernández MT, Paiva B, Cedena Romero MT, Puig N, Lahuerta JJ, Bladé J, San-Miguel J, Mateos MV .
Grupo de trabajo coautor: GEM .
• Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bor- tezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022) . New Orleans, LA, USA: 10-13 Dec 2022 . Hybrid event .
Mateos MV, San-Miguel J, Cavo M, Bladé Creixenti J, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Grosicki S, Crepaldi AH, Liberati AM, Campbell P, She- lekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Pei H, Krevvata M, Carson R, Borgsten F, Dimopoulos MA .
Grupo de trabajo coautor: GEM .
95